Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML).
van den Heuvel-Eibrink
M M
MM
Wiemer
E A
EA
Kuijpers
M
M
Pieters
R
R
Sonneveld
P
P
D003561:Cytarabine / Q000378:metabolism / Q000627:therapeutic use; D003842:Deoxycytidine Kinase / Q000235:genetics*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics*; D009154:Mutation; D012008:Recurrence
D003561:Cytarabine; D003842:Deoxycytidine Kinase